ReviewCancer2020
Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC).
J Nicholas Bodor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
200 papers cite itlatest 60 shown
this paperpooled ittrialcites it